Activist hedge fund Elliott Management is calling on GlaxoSmithKline plc to listen to offers for its Consumer Healthcare business as an alternative to its plan to spin-off and list the business on the London Stock Exchange next year.
“Any strategic opportunity for the sale of Consumer Healthcare should be diligently pursued and accompanied by a clear plan for...





